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Abstract
Background  and  objectives: 15q  tetrasomy  is  a  chromosomal  abnormality  that  is  a  part  of  the
heterogeneous  group  of  extra  structurally  abnormal  chromosomes.  This  syndrome  is  charac-
terized by  epilepsy,  central  hypotonia,  developmental  delay  and  intellectual  disability,  and
autistic behavior.  This  is  the  ﬁrst  report  of  the  anesthetic  management  of  a  patient  with  this
syndrome.
Case report: We  administered  general  anesthesia  for  dental  treatment  in  a  patient  with  15q
tetrasomy.
Conclusions:  Appropriate  planning  for  the  prevention  of  complications  such  as  seizures  and
hypotonia,  and  for  delayed  emergence  from  anesthesia,  is  required.  Speciﬁcally,  choosing
short-acting  drugs  that  do  not  induce  seizures,  together  with  suitable  monitoring,  resulted
in successful  anesthetic  management  of  the  patient  with  15q  tetrasomy.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
PALAVRAS-CHAVE
Tetrassomia  do
cromossomo  15q;
Anestesia  geral;
Manejo  anestésico  de  paciente  com  tetrassomia  15q  para  tratamento  odontológico
Resumo
Justiﬁcativa  e  objetivos:  Tetrassomia  15q  é  uma  anomalia  cromossômica  que  faz  parte  do  grupoTratamento heterogêneo  de  cromossomos  extras,  estruturalmente  anormais.  Essa  síndrome  é  caracterizada
ntral,  atraso  no  desenvolvimento  e  deﬁciência  intelectual  e  com-
 o  primeiro  relato  do  manejo  anestésico  de  um  paciente  com  essa
mos  anestesia  geral  para  tratamento  odontológico  em  um  pacienteodontológico por epilepsia,  hipotonia  ce
portamento  autista.  Este  é
síndrome.
Relato de  caso:  Administra
com tetrassomia  15q.Please  cite  this  article  in  press  as:  Hase  Y,  et  al.  Anesthetic  management  of  a  patient  with  15q  tetrasomy  for  dental
treatment.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.09.002
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0104-0014/© 2016 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusões:  Um  planejamento  adequado  para  prevenir  complicac¸ões  como  convulsões  e  hipo-
tonia e  para  emergência  tardia  da  anestesia  é  necessário.  O  manejo  anestésico  bem-sucedido
do paciente  com  tetrassomia  15q  foi  o  resultado  especiﬁco  da  escolha  de  medicamentos  de
curta durac¸ão  que  não  induzem  convulsões  e  monitorizac¸ão  adequada.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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hromosome  15q  tetrasomy  is  a  constituent  of  the  heteroge-
eous  group  of  extra  structurally  abnormal  chromosomes.1
his  syndrome  displays  distinctive  clinical  features,  such  as
pilepsy,  central  hypotonia,  developmental  delay  and  intel-
ectual  disability,  and  autistic  behavior.1 Incidence  at  birth
s  estimated  at  1  in  30,000;  but  no  previous  reports  have
escribed  the  anesthetic  management  of  a  patient  with  this
yndrome.
ase report
he  patient  was  a  25  year-old  man  (height,  153  cm;  weight,
1  kg)  who  was  scheduled  for  extraction  of  four  impacted
isdom  teeth  and  scaling  under  general  anesthesia.  He  had
 history  of  difﬁculty  in  sucking  and  feeding  from  birth  and
ad  started  walking  at  the  age  of  2.5  years,  because  of
evelopmental  delay  and  hypotonia.  He  had  no  medical  his-
ory  of  aspiration  pneumonitis.  He  was  diagnosed  with  15q
artial  tetrasomy  syndrome  at  the  age  of  8  years.  He  had
xperienced  frequent  generalized  seizures  since  he  was  7
ears  old,  and  had  been  treated  with  clobazam  and  car-
amazepine.  He  showed  autistic  or  autistic-like  features.
lthough  he  had  severe  intellectual  disability,  he  could
peak  one-word  sentences  and  follow  simple  instructions.
lood  examinations  and  ECG  were  unremarkable,  except
or  slight  liver  dysfunction.  He  had  a  history  of  delayed
mergence  from  general  anesthesia  5  years  earlier  at  our
epartment.
On  the  day  of  the  dental  procedure,  the  patient  entered
he  operating  room  and  did  not  offer  resistance  to  the
onitors  being  worn.  Slow  induction  was  performed  with
%  sevoﬂurane  and  100%  oxygen  (6  L/min),  following  which
n  intravenous  catheter  was  inserted  and  left  in  place,
nd  fentanyl,  thiamylal  and  rocuronium  were  administered.
fter  uneventful  mask  ventilation,  nasal  intubation  was  per-
ormed  with  a  6.5  mm  cuffed  Nasal  RAETM endotracheal  tube
nder  direct  visualization  of  the  glottis.  General  anesthe-
ia  was  maintained  with  air,  oxygen,  desﬂurane  (fraction
f  inspired  oxygen  =  0.4)  and  remifentanil  under  controlled
entilation.  Immediately  after  the  induction  of  anesthesia,
he  Train  Of  Four  Ratio  (TOFR)  was  0,  increasing  to  0.6  after
0  min.  By  the  start  of  the  surgery,  it  had  reached  0.9.  The
ispectral  Index  (BIS)  value  during  the  surgery  was  main-Please  cite  this  article  in  press  as:  Hase  Y,  et  al.  Anesthetic  
treatment.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.10
ained  between  50  and  65,  without  any  unexpected  large
ariations  in  the  value.  His  vital  signs  remained  stable  with  a
lood  pressure  of  80--90/40--50  mmHg,  heart  rate  of  60  bpm,
pO2 of  99%--100%.  Sugammadex  was  administered  after  the
r
i
e
ourgery  and  extubation  was  performed  after  conﬁrming  that
uscle  function  was  fully  restored,  as  indicated  by  a  TOFR
f  1.0.  The  operative  time  was  74  min  and  anesthesia  time
as  146  min.  The  patient  was  discharged  on  the  following
ay  without  any  problems  such  as  perioperative  respiratory
omplications  and  seizures.
iscussion
hromosome  15q  tetrasomy  is  also  known  as  inverted
uplication  15  (inv  dup[15])  or  isodicentric  chromosome
5  (idic[15]).2 It  is  caused  by  an  extra  inv  dup(15)
arker  chromosome,  cytogenetically  deﬁned  as  inv  dup(15)
pter  →  q12-13:  q12-13  →  pter)  by  FISH  analysis.1 Our
atient’s  karyotype  was  47,  XY,  +  idic(15)(q12),  i.e.  tetra-
omy  with  the  extra  derived  chromosome  at  15q11-q12.  15q
etrasomy  is  clinically  associated  with  seizures,  hypotonia,
evelopmental  delays,  intellectual  disability,  congenital
eart  defects,  brain  abnormalities,  and  dysmorphic  facial
eatures,  such  as  downslanting  palpebral  ﬁssures,  low
et  ears,  micrognathia,  prominent  mandible,  and  cleft
alate.1,2 15q11-q13  is  considered  a  prime  candidate  region
or  the  mapping  of  epilepsy  genes  and  the  relationship  with
utism.2,3 Gene  tetrasomy  may  alter  GABA  receptor  activ-
ty  upon  which  the  major  CNS  inhibitory  mechanisms  rely.1
5q  tetrasomy  affects  encoding  of  GABAA receptor  subunits
GABRB3,  GABRA5,  GABRG3),  which  is  related  to  the  seizures
nd  autism  associated  with  this  syndrome.3 Some  reports
how  high  complication  rates  of  seizures  in  15q  tetrasomy
atients  (63%--75%).1,3 Therefore,  the  challenges  for  anes-
hesiologists  managing  such  patients  are  attacks  of  seizures,
erioperative  respiratory  complication  and  prolonged  mus-
le  relaxation  related  to  hypotonia,  and  difﬁcult  airways.
The  following  ﬁve  points  were  considered  when  we
lanned  the  anesthetic  management  for  the  present  patient.
irst,  for  the  prevention  of  seizures,  the  patient  took  his
egular  antiepileptic  medicines  on  the  day  of  surgery,  and
hiamylal,  which  has  anticonvulsant  effects,  was  injected
t  the  induction  of  anesthesia.  We  also  had  to  examine  the
edicines  which  were  substituted  for  the  regular  ones  in
ase  the  patient  could  not  ingest  orally  perioperatively.  Des-
urane  is  a  suitable  drug  for  use  in  patients  with  epilepsy
ince  it  does  not  have  epileptiform  activity4 while  there  have
een  several  reports  of  epileptoid  EEG  patterns  observed
nder  sevoﬂurane  anesthesia.5 It  is  quite  difﬁcult  to  observe
 seizure  during  general  anesthesia.  However,  previousmanagement  of  a  patient  with  15q  tetrasomy  for  dental
16/j.bjane.2016.09.002
eports  have  shown  that  abnormal  ﬂuctuations  or  decreases
n  BIS  values  under  anesthesia  resulted  from  occurrences  of
pileptiform  EEG  activity,  and  that  BIS  monitoring  might  not
nly  give  useful  information  on  the  sedative-hypnotic  state,
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Anesthetic  management  of  a  patient  with  15q  tetrasomy  for
but  also  on  the  development  of  abnormal  epileptiform  EEG
activity.5 Therefore,  we  monitored  the  depth  of  anesthesia
during  surgery  and  observed  for  ﬂuctuations  in  BIS  values.
Second,  hypotonia,  which  might  lead  to  serious  anes-
thetic  complications,  should  be  considered  in  these
patients.  Generally,  hypotonia  is  associated  with  a  prolonged
effect  of  non-depolarizing  muscle  relaxants.  In  this  case,
rocuronium  was  administered  only  at  the  time  of  anesthesia
induction  and  neuromuscular  monitoring  was  continuously
performed  during  anesthesia.  At  the  previous  anesthetic
management  of  this  patient,  vecuronium,  which  has  a longer
duration  of  action  as  compared  with  rocuronium,  and  an
anti-cholinesterase  agent  for  which  the  reversal  effect  is
incomplete  compared  with  sugammadex,  were  used  for
this  patient,  which  was  considered  the  cause  of  the  resid-
ual  muscle  relaxation  effect.  Muscle  hypotonia  with  joint
hyperextensibility  and  drooling  is  observed  in  almost  all  indi-
viduals  with  15q  tetrasomy,1 which  can  result  in  aspiration.
For  this  reason,  we  anticipated  the  risk  of  postoperative
aspiration,  although  the  patient  had  no  history  of  aspiration.
Fortunately,  no  worsening  of  the  hypotonia  or  respiratory
deterioration  was  seen  perioperatively  in  this  patient.
Third,  at  the  time  of  the  patient’s  anesthetic  manage-
ment  5  years  earlier,  the  total  anesthesia  time  was  100  min,
including  approximately  30  min  for  emergence.  Prolonged
emergence  at  that  time  might  have  been  caused  by  the  fol-
lowing:  (1)  Enhanced  anesthetic  effect  due  to  a  synergistic
effect  with  the  anticonvulsant.  (2)  Sevoﬂurane,  which  has  a
higher  partition  coefﬁcient  than  desﬂurane,  was  used  dur-
ing  the  maintenance  of  anesthesia.  Therefore,  during  the
current  anesthesia,  we  used  desﬂurane  and  remifentanil
for  maintenance  under  BIS  monitoring.  As  a  result,  delayed
emergence  did  not  occur.  Extubation  was  performed  only
10  min  after  the  end  of  surgery  without  residual  effects
of  narcotics.  On  the  other  hand,  anticonvulsants  act  on
drug  metabolizing  enzymes  and  consequently  increase  the
requirement  of  opioids  and  muscle  relaxants.  Therefore,
careful  attention  has  to  be  paid  to  the  dose  of  drugs  related
to  anesthesia,  maintaining  a  balance  between  preventing
convulsions  due  to  light  anesthesia,  and  avoiding  prolonged
emergence  and  prolonged  effects  of  muscle  relaxants  due
to  increased  anesthetic  effects.
Fourth,  anticipating  the  patient’s  lack  of  cooperation
at  the  time  of  anesthesia  induction,  due  to  his  autistic-
like  behavior,  he  practiced  with  the  visual  material  of  the
TEACCH  method6 used  for  autistic  patients  at  the  preoper-
ative  anesthesia  consultation,  to  familiarize  him  with  the
anesthesia  induction  period  and  facilitate  a  smooth  induc-
tion.  This  resulted  in  a  successful  induction.
Finally,  preoperative  evaluation  of  the  patient  for  a  dif-
ﬁcult  airway  is  important,  since  patients  with  this  syndrome
sometimes  display  maxillofacial  abnormalities.  The  patient
did  not  have  any  features  that  suggested  the  likelihood  of  a
difﬁcult  airway.
We administered  sugammadex  at  the  end  of  the  anes-
thesia  though  TOFR  had  reached  1.0  for  more  safety  of
the  patient.  It  is  necessary  to  control  neuromuscular  block
exactly  especially  in  this  patient  with  hypotonia  as  men-Please  cite  this  article  in  press  as:  Hase  Y,  et  al.  Anesthetic  
treatment.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.10
tioned  previously  and  the  reaction  to  muscle  relaxants  was
not  predictable  because  there  was  no  report  of  the  anes-
thetic  management  of  a  patient  with  15q  tetrasomy  in
the  past.  Even  at  a  TOFR  >  0.9  or  1.0  measured  at  the PRESS
tal  treatment  3
dductor  pollicis  muscle,  some  subjects  still  have  impaired
haryngeal  or  respiratory  function.7 Although  TOF  monitor-
ng  is  important,  the  evaluation  of  the  clinical  signs  is  also
ecessary.8 However,  we  could  not  observe  the  correct  and
eliable  response  or  signs  to  our  instructions  because  this
atient  had  severe  intellectual  disability.  We  needed  both
he  reversal  of  muscle  relaxant  to  make  up  for  clinical  signs
nd  TOF  as  an  objective  monitoring.
As  this  is  the  ﬁrst  report  of  the  anesthetic  management  of
 patient  with  15q  tetrasomy,  the  problems  that  may  occur
t  the  time  of  anesthetic  management  due  to  the  clinical
eatures  associated  with  the  chromosome  abnormality  are
ot  well  known.  Hence,  we  reviewed  the  previous  anesthetic
eports  of  patients  with  genetically  similar  diseases.  Chro-
osome  region  15q11-q13  is  known  for  its  instability,  and
he  genetically  damaged  segment  in  15q  tetrasomy  is  almost
he  same  as  in  Prader-Willi  Syndrome  (PWS)  and  Angelman
yndrome  (AS).  15q  tetrasomy  is  derived  from  overexpress-
on  of  the  chromosome  15q11-q13  region  that  is  maternal  in
rigin,  while  PWS  is  mainly  caused  by  deletion  of  paternally
xpressed  gene,  and  AS  is  caused  by  deletion  of  maternally
xpressed  UBE3A  gene  of  derived  15q11-q13  region.3 Due  to
ypotonia,  prolonged  muscle  relaxant  effects  during  general
nesthesia  have  been  previously  reported  in  patients  with
WS  and  AS.9,10 Moreover,  the  deletion  of  GABAA receptor  in
S11 may  cause  resistance  to  GABA-stimulating  anesthetics,
uch  as  propofol.  In  fact,  an  animal  experiment  of  AS  showed
ore  reduction  in  drug  sensitivity  to  propofol  than  inhala-
ion  anesthetics.12 However,  although  it  is  not  clear  whether
he  same  reaction  to  anesthetics  as  in  AS  are  observed  in
atients  with  15q  tetrasomy  as  well,  we  carefully  moni-
ored  BIS  during  anesthesia  in  the  present  patient.  More
tudies  on  the  relationship  between  15q  tetrasomy  and  var-
ous  anesthetic  agents,  by  collecting  more  case  reports  and
y  conducting  genetic  research,  would  be  useful.
onclusion
e  administered  general  anesthesia  to  a  patient  with  15q
etrasomy.  In  such  patients,  it  is  important  to  make  efforts
or  the  prevention  of  complications  such  as  seizures  and
ypotonia,  and  to  avoid  prolonged  emergence.  In  conclu-
ion,  the  use  of  short-acting  drugs  that  do  not  induce  seizure
nd  suitable  monitoring  resulted  in  successful  anesthetic
anagement  of  15q  tetrasomy.
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